Mar 22, 2024
- Mar 21, 2025
The New Era of Biosimilar Therapeutics for Multiple Sclerosis
0.75

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Nephrology
Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...
Gastroenterology
Update on Advanced Treatment Plans to Improve Outcomes for Patients with Primary Biliary C...
Cardiometabolic
Update From ESC24: New Data on Non-Statin Lipid Lowering Therapies and Reduced CV Risk